Cargando…

Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice

SIMPLE SUMMARY: In earlier times, for patients with breast cancer who have metastases in distant organs, e.g., the lung, the mainstay of treatment was confined to chemotherapy. In recent years, additional therapeutic options have evolved as high-throughput commercial testing can identify alterations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruzas, Simona, Kuemmel, Sherko, Harrach, Hakima, Breit, Elisabeth, Ataseven, Beyhan, Traut, Alexander, Rüland, Anna, Kostara, Athina, Chiari, Ouafaa, Dittmer-Grabowski, Christine, Reinisch, Mattea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468801/ https://www.ncbi.nlm.nih.gov/pubmed/34572791 http://dx.doi.org/10.3390/cancers13184564

Ejemplares similares

Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
por: Reinisch, Mattea, et al.
Publicado: (2023)

Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy
por: Reinisch, Mattea, et al.
Publicado: (2023)

Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers
por: Reinisch, Mattea, et al.
Publicado: (2021)

Olaparib for metastatic breast cancer in a patient with a germline PALB2 variant
por: Kuemmel, Sherko, et al.
Publicado: (2020)

Gene signatures in patients with early breast cancer and relapse despite pathologic complete response
por: Bruzas, Simona, et al.
Publicado: (2022)

Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience
por: Moubarak, Malak, et al.
Publicado: (2022)

Efficacy and Safety of Auricular Acupuncture for the Treatment of Insomnia in Breast Cancer Survivors: A Randomized Controlled Trial
por: Höxtermann, Melanie D., et al.
Publicado: (2021)

RESPONDER – diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial
por: Heil, Joerg, et al.
Publicado: (2018)

The INTREST registry: protocol of a multicenter prospective cohort study of predictors of women’s response to integrative breast cancer treatment
por: Haller, Heidemarie, et al.
Publicado: (2021)

Hypoglossal acupuncture for acute chemotherapy-induced dysgeusia in patients with breast cancer: study protocol of a randomized, sham-controlled trial
por: Haller, Heidemarie, et al.
Publicado: (2019)

Autologous vs. implant-based breast reconstruction after skin- and nipple-sparing mastectomy—A deeper insight considering surgical and patient-reported outcomes
por: von Glinski, Maxi, et al.
Publicado: (2022)

The Partner Perspective on Autologous and Implant-Based Breast Reconstruction
por: von Glinski, Maxi, et al.
Publicado: (2023)

Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Heitz, Florian, et al.
Publicado: (2019)

Prevalence of BRCA1 and BRCA2 Mutations in Patients with Primary Ovarian Cancer – Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequately Depict the Need for Consultation?
por: Ataseven, Beyhan, et al.
Publicado: (2020)

Response to the letter of Fagotti et al. regarding the manuscript: “Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery”
por: Heitz, Florian, et al.
Publicado: (2016)

Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients
por: Imterat, Majdi, et al.
Publicado: (2023)

Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer
por: Heitz, Florian, et al.
Publicado: (2023)

Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques
por: Heil, Joerg, et al.
Publicado: (2015)

BRCA2 Mutations and Triple-Negative Breast Cancer
por: Meyer, Peter, et al.
Publicado: (2012)

Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors
por: Plett, Helmut, et al.
Publicado: (2020)

Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers
por: Bayle, Arnaud, et al.
Publicado: (2021)

Tear analysis as the next routine body fluid test
por: Barmada, Anis, et al.
Publicado: (2020)

The Search for the Ideal Female Breast: A Nationally Representative United-States-Census Study
por: Wallner, Christoph, et al.
Publicado: (2022)

Integrative oncology for breast cancer patients: introduction of an expert-based model
por: Dobos, Gustav J, et al.
Publicado: (2012)

Targeted next-generation sequencing for routine clinical screening of mutations
por: Weaver, Jamie MJ, et al.
Publicado: (2011)

Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer—Impact for Diagnosis and Treatment Monitoring
por: Braicu, Elena Ioana, et al.
Publicado: (2021)

PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs
por: Ataseven, Beyhan, et al.
Publicado: (2014)

Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire
por: Herold, Natalie, et al.
Publicado: (2022)

Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator
por: Vlaicu, Philip, et al.
Publicado: (2013)

PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
por: Gärtner, Silvia, et al.
Publicado: (2014)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Uncommon mutational profiles of metastatic colorectal cancer detected during routine genotyping using next generation sequencing
por: Franczak, Claire, et al.
Publicado: (2019)

Expanding the Molecular Disturbances of Lipoproteins in Cardiometabolic Diseases: Lessons from Lipidomics
por: Kostara, Christina E.
Publicado: (2023)

Localized Surface Plasmon Resonance Biosensing: Current Challenges and Approaches
por: Unser, Sarah, et al.
Publicado: (2015)

The time has come for next-generation sequencing in routine diagnostic workup in hematology
por: Haferlach, Torsten
Publicado: (2021)

Operationalising targeted next-generation sequencing for routine diagnosis of drug-resistant TB
por: Iyer, A., et al.
Publicado: (2023)

Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis
por: Eggemann, Holm, et al.
Publicado: (2019)

Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis
por: Eggemann, Holm, et al.
Publicado: (2020)

Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review
por: Cuyún Carter, Gebra, et al.
Publicado: (2021)

A Null Mutation of TNFRSF11A Causes Dysosteosclerosis, Not Osteopetrosis
por: Kırkgöz, Tarık, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4n9vl8j9o1k7lde9ef8vt78ndp